Arkolith/Insider Trading/TRDA/Form 4

Sethuraman Natarajan

President, Research & Develop.Entrada Therapeutics, Inc. (TRDA) · full profile →Form 4 · filed Dec 3, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$321K
Net Open-Market Flow
-$321K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 3, 2024Sell(S)12K$20.15$236K145K
Dec 2, 2024Sell(S)4K$20.26$83K157K
Nov 29, 2024Sell(S)100$20.00$2K161K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001689375-24-000067) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML